type in your search and press enter
You May Also Like
GeneSight® Shown to Statistically Significantly Improve Generalized Anxiety Disorder Treatment Response and Decrease Benzodiazepine Use
SALT LAKE CITY, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Assurex Health, a wholly-owned subsidiary ...
DeGen Medical Receives Clearance of F1 MPS(TM) System for JOUST(TM) Minimally Invasive Surgical Procedure
FLORENCE, S.C., July 26, 2016 (GLOBE NEWSWIRE) -- DeGen Medical has received clearance from ...
XBiotech Announces Agreement with Cedars-Sinai Medical Center to Evaluate MABp1 in Combination with OnivydeⓇ and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer
AUSTIN, Texas, Sept. 20, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today its ...
